GIMOTI is a Nasal Spray in the Human Prescription Drug category. It is labeled and distributed by Evoke Pharma, Inc.. The primary component is Metoclopramide Hydrochloride.
| Product ID | 72089-307_500df880-ef27-4641-8760-0e19e9adf0f9 | 
| NDC | 72089-307 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | GIMOTI | 
| Generic Name | Metoclopramide Hydrochloride | 
| Dosage Form | Spray | 
| Route of Administration | NASAL | 
| Marketing Start Date | 2020-06-19 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA209388 | 
| Labeler Name | Evoke Pharma, Inc. | 
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE | 
| Active Ingredient Strength | 15 mg/.07mL | 
| Pharm Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2020-06-19 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 72089-307 | GIMOTI | GIMOTI | 
| 0121-0576 | Metoclopramide | metoclopramide hydrochloride | 
| 0121-1576 | Metoclopramide | metoclopramide hydrochloride | 
| 0404-9910 | Metoclopramide | Metoclopramide Hydrochloride | 
| 17856-0537 | Metoclopramide | metoclopramide hydrochloride | 
| 17856-0576 | Metoclopramide | metoclopramide hydrochloride | 
| 17856-3727 | Metoclopramide | metoclopramide hydrochloride | 
| 23155-240 | Metoclopramide | Metoclopramide Hydrochloride | 
| 50436-0576 | Metoclopramide | metoclopramide hydrochloride | 
| 52584-414 | Metoclopramide | Metoclopramide Hydrochloride | 
| 55154-2353 | Metoclopramide | METOCLOPRAMIDE HYDROCHLORIDE | 
| 0115-1651 | Metoclopramide Hydrochloride | Metoclopramide Hydrochloride | 
| 0115-1652 | Metoclopramide Hydrochloride | Metoclopramide Hydrochloride | 
| 0615-8038 | Metoclopramide Hydrochloride | Metoclopramide Hydrochloride | 
| 0615-8071 | Metoclopramide Hydrochloride | Metoclopramide Hydrochloride | 
| 40032-580 | METOCLOPRAMIDE hydrochloride | Metoclopramide Hydrochloride | 
| 40032-581 | METOCLOPRAMIDE hydrochloride | Metoclopramide Hydrochloride | 
| 42254-196 | Metoclopramide Hydrochloride | Metoclopramide Hydrochloride | 
| 42254-266 | Metoclopramide Hydrochloride | Metoclopramide Hydrochloride | 
| 43353-808 | Metoclopramide Hydrochloride | Metoclopramide Hydrochloride | 
| 43386-580 | METOCLOPRAMIDE hydrochloride | Metoclopramide Hydrochloride | 
| 43386-581 | METOCLOPRAMIDE hydrochloride | Metoclopramide Hydrochloride | 
| 53808-0623 | Metoclopramide Hydrochloride | Metoclopramide Hydrochloride | 
| 55154-0450 | Metoclopramide hydrochloride | Metoclopramide hydrochloride | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  GIMOTI  88512443  not registered Live/Pending | EVOKE PHARMA, INC. 2019-07-12 | 
|  GIMOTI  86815848  not registered Dead/Abandoned | Evoke Pharma, Inc. 2015-11-10 |